BridgeMD
New treatment option for Infant, Premature
Official title Personalized Music Therapy for Preterm Infants
ClinicalTrials.gov ID: NCT07295106
What this study is testing
- What it's testing
- Preterm infants in the Neonatal Intensive Care Unit (NICU) face environmental and clinical stressors that may affect physiological stability and development. This pilot randomized crossover study tests Personalized Music Therapy (PMT) based on recorded parental voices versus Quiet Rest.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 5 to 15
You may be able to join if
- Preterm infants admitted to the Neonatal Intensive Care Unit (NICU) of Azienda Ospedaliera di Perugia, Santa Maria della Misericordia, Perugia...
- Gestational age at birth 28+0 to 36+6 weeks.
- Age at enrollment: 5 to 15 days.
- Stable vital signs at enrollment per unit policy.
- Apgar score at 5 minutes ≥ 7.
You likely can't join if
- Post-operative status at the time of enrollment.
- One or more of the following: intraventricular hemorrhage, necrotizing enterocolitis, sepsis, significant pulmonary disease, or neonatal anemia.
- Congenital anomalies.
- Hypersensitivity or intolerance to sound.
- Maternal history of drug and/or alcohol misuse during pregnancy.
- Lack of parental consent.
See the full eligibility criteria
- Preterm infants admitted to the Neonatal Intensive Care Unit (NICU) of Azienda Ospedaliera di Perugia, Santa Maria della Misericordia, Perugia (Italy) at the time of enrollment.
- Gestational age at birth 28+0 to 36+6 weeks.
- Age at enrollment: 5 to 15 days.
- Stable vital signs at enrollment per unit policy.
- Apgar score at 5 minutes ≥ 7.
- Birth weight appropriate for gestational age, between the 50th and 90th percentile.
- Written informed consent from parent(s) or legal guardian(s).
- Post-operative status at the time of enrollment.
- One or more of the following: intraventricular hemorrhage, necrotizing enterocolitis, sepsis, significant pulmonary disease, or neonatal anemia.
- Congenital anomalies.
- Hypersensitivity or intolerance to sound.
- Maternal history of drug and/or alcohol misuse during pregnancy.
- Lack of parental consent.
The study team makes the final eligibility decision.
Where it's taking place
- Perugia, PG, Italy
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 5 days to 15 days. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Perugia, PG, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.